Healthcare Services (Clinical Laboratory Service and Radiological Service) (Amendment) Regulations 2023

No. S 417

Healthcare Services Act 2020

Healthcare Services
(Clinical Laboratory Service and
Radiological Service) (Amendment)
Regulations 2023

In exercise of the powers conferred by section 57 of the Healthcare Services Act 2020, the Minister for Health makes the following Regulations:

Citation and commencement

1. These Regulations are the Healthcare Services (Clinical Laboratory Service and Radiological Service) (Amendment) Regulations 2023 and come into operation on 26 June 2023.

Amendment of regulation 2

2. In the Healthcare Services (Clinical Laboratory Service and Radiological Service) Regulations 2021 (G.N. No. S 1036/2021) (called in these Regulations the principal Regulations), in regulation 2 —

(a)

after the definition of “business name”, insert —

“ “calendar day” includes Saturday, Sunday and every public holiday;”;

(b)

after the definition of “Clinical Governance Officer”, insert —

“ “clinical laboratory service” has the meaning given by paragraph 2 of the First Schedule to the Act;”;

(c)

replace the definition of “collaborative prescribing practitioner” with —

“ “collaborative prescribing practitioner” has the meaning given by regulation 2 of the Healthcare Services (Collaborative Prescribing Service) Regulations 2023 (G.N. No. S 398/2023);

“expiry date”, in relation to any reagent or testing material, means —

(a)	the date after which; or
(b)	the month and year after the end of which,

as the case may be, the reagent or testing material should not be used;”;

(d)

replace the definitions of “imaging modality” and “laboratory discipline” with —

“ “imaging modality” means —

(a)	any imaging modality set out in paragraph 1(a) of Part 2 of the Schedule;
(b)	bone densitometry; or
(c)	ultrasound;

“imaging service” means the use of ionising or non‑ionising radiation for any of the following purposes:

(a)	examination of the body, or any matter derived from the body, of an individual;
(b)	assessment of the health or condition of an individual;
(c)	observation and diagnosis of a condition, disability, disease, disorder or an injury of the body or mind of an individual;
(d)	determining, predicting or providing a prognosis of the health or condition of an individual;

“laboratory discipline” means any laboratory discipline set out in paragraph 1(a) of Part 1 of the Schedule;”;

(e)

after the definition of “personnel”, insert —

“ “radioactive specimen” means any specimen —

(a)	on which a radioactive substance is applied for the purpose of a test or examination of the specimen; or
(b)	that is derived, obtained or excreted from an individual who was administered a radiopharmaceutical for the purpose of testing or examining the specimen, whether or not the specimen contains any radioactive substance;

“radioactive substance” has the meaning given by section 2(1) of the Radiation Protection Act 2007;

“radiological service” has the meaning given by paragraph 2 of the First Schedule to the Act;”;

(f)

after the definition of “radiological service licensee”, insert —

“ “radiopharmaceutical” means any unsealed source (within the meaning given by regulation 2 of the Radiation Protection (Ionising Radiation) Regulations 2023 (G.N. No. S 85/2023)) that is administered to a patient as a diagnostic agent;”; and

(g)

replace the definitions of “specified test”, “specimen” and “test” with —

“ “simple in vitro diagnostic test” has the meaning given by paragraph 2 of the First Schedule to the Act;

“specimen” has the meaning given by regulation 2 of the General Regulations;

“temporary premises” means any premises other than permanent premises;

“test” means an analysis or examination of a specimen conducted by a licensee in connection with the provision of a clinical laboratory service;

“testing material” means any test kit, material, device, equipment, instrument or other article that is used to conduct a simple in vitro diagnostic test;

“testing service” means the examination or testing of any matter derived, obtained or excreted from the body of any individual for the purpose of —

(a)	assessing the health or genetic predisposition of that individual or any other individual;
(b)	predicting or providing a prognosis of the health condition of that individual or any other individual;
(c)	diagnosing a condition, disability, disease, disorder or an injury of the body or mind of that individual or any other individual;
(d)	determining the intervention to be taken, or the effect of any intervention taken, of a condition, disability, disease, disorder or an injury of the body or mind of an individual;
(e)	ascertaining the result of a medical or surgical treatment given to that individual or any other individual; or
(f)	assessing the health, condition or suitability of any human biological material that is used, or is intended to be used, in relation to any healthcare service.”.

Replacement of regulation 4 and new regulations 4A and 4B

3. In the principal Regulations, replace regulation 4 with —

“Specified services

4. For the purposes of section 9A(1) of the Act —

(a)	the services set out in Part 1 of the Schedule are specified services for a clinical laboratory service; and
(b)	the services set out in Part 2 of the Schedule are specified services for a radiological service.

Notification of certain imaging modalities

4A.—(1) For the purposes of section 10(2)(c)(viii) of the Act, an applicant for the grant or renewal of a licence to provide a radiological service must specify in the licence application whether the applicant provides, or intends to provide an imaging service by bone densitometry or ultrasound as part of that service.

(2) A radiological service licensee who, during the term of the licence, intends to provide an imaging service by bone densitometry or ultrasound as part of the radiological service must, no later than 2 months before the licensee intends to start providing the imaging service by that imaging modality, give written notice to the Director‑General of the licensee’s intention.

(3) A radiological service licensee who, during the term of the licence, intends to stop providing an imaging service by bone densitometry or ultrasound as part of the radiological service must, no later than 10 calendar days before the licensee intends to stop providing the imaging service by that imaging modality, give written notice to the Director‑General of the licensee’s intention.

Prohibited service delivery modes

4B.—(1) A licensee must not provide a clinical laboratory service or radiological service by remote provision.

(2) A clinical laboratory service licensee must not provide any of the following specified services using a conveyance or at temporary premises:

(a)	a testing service in a laboratory discipline specified in paragraph 1(a)(i), (iv), (v), (vii), (ix), (x) or (xi) of Part 1 of the Schedule;
(b)	a test set out in paragraph 1(b)(iii), (iv) or (v) of Part 1 of the Schedule.

(3) A radiological service licensee must not provide any of the following specified services using a conveyance or at temporary premises:

(a)	an imaging service by an imaging modality specified in paragraph 1(a)(iii), (iv), (v) or (vi) of Part 2 of the Schedule;
(b)	a procedure set out in paragraph 1(b) of Part 2 of the Schedule.”.

Amendment of regulation 5

4. In the principal Regulations, in regulation 5 —

(a)	in the regulation heading, delete “licensee”; and
(b)	delete “licensee”.

Amendment of regulation 6

5. In the principal Regulations, in regulation 6 —

(a)	in the regulation heading, delete “licensee”;
(b)	in paragraph (1), delete “licensee”; and
(c)	in paragraph (2), after “Clinical Governance Officer”, insert “for the radiological service”.

Amendment of regulation 7

6. In the principal Regulations, in regulation 7 —

(a)	in paragraphs (1) and (2), delete “licensee”; and
(b)	in paragraphs (1)(b) and (2)(b), after “implement”, insert “and oversee”.

Amendment of regulation 8

7. In the principal Regulations, in regulation 8 —

(a)

in paragraph (1), replace “laboratory discipline” with “specified service”;

(b)

in paragraph (2), after “imaging modality” wherever it appears, insert “or specified service”; and

(c)

replace paragraph (3) with —

“(3) A person may be appointed as a section leader —

(a)	in relation to a clinical laboratory service — for more than one specified service; or
(b)	in relation to a radiological service — for more than one imaging modality or specified service.”.

Amendment of regulation 9

8. In the principal Regulations, in regulation 9, replace “laboratory discipline or imaging modality” wherever it appears with “imaging modality or specified service”.

Amendment of regulation 11

9. In the principal Regulations, in regulation 11(2), after sub‑paragraph (f), insert —

“(fa)

where the licensee provides any testing service on radioactive specimens —

(i)

quality control measures for all radioactive substances kept and used by the licensee, including measures pertaining to —

(A)	the acceptance, or rejection for quality or safety reasons, of all radioactive substances supplied to the licensee;
(B)	the safe and proper preparation, handling, transport and use of the radioactive substances; and
(C)	the regular testing of the quality and safety of the radioactive substances;

(ii)

the maintenance of adequate and accurate documentation on the licensee’s use of radioactive substances;

(iii)

the conduct of regular holistic analysis and reviews of all information relating to —

(A)	the quality and safety of all radioactive substances kept and used by the licensee; and
(B)	the applicable licensee’s use of all radioactive substances; and

(iv)

the testing and monitoring of the radiation levels in every approved permanent premises to ensure the safety of personnel, patients and visitors;”.

Amendment of regulation 12

10. In the principal Regulations, in regulation 12 —

(a)

replace paragraph (1) with —

“(1) A licensee must ensure that —

(a)	every approved permanent premises, approved conveyance and temporary premises where the applicable service is provided has adequate space for the licensee to carry out the applicable service in a safe manner;
(b)	every approved permanent premises or approved conveyance is adequately secured to prevent unauthorised access to the approved permanent premises or approved conveyance; and
(c)	every temporary premises (other than any residential premises) at which the applicable service is provided is adequately secured to prevent unauthorised access to the premises.”;

(b)

in paragraph (2)(a), replace sub‑paragraph (i) with —

“(i)	adequate storage space at every approved permanent premises, approved conveyance or temporary premises where the applicable service is provided;”;

(c)

in paragraph (2)(b), replace “the licensed premises or licensed conveyance” with “every approved permanent premises, approved conveyance or temporary premises where the applicable service is provided”;

(d)

in paragraph (2), replace sub‑paragraph (c) with —

“(c)	appropriate safety equipment is provided in every approved permanent premises, approved conveyance or temporary premises where the applicable service is provided;”; and

(e)

after paragraph (2), insert —

“(3) Where a licensee provides any testing service on radioactive specimens, the licensee must also ensure that all of the following requirements are satisfied:

(a)

in relation to the receipt, use, preparation, storage and disposal of radioactive substances —

(i)	adequate space is provided at every approved permanent premises; and
(ii)	the space provided is secure and access to the space is controlled;

(b)

appropriate radiation shielding is provided at any part of every approved permanent premises where procedures involving the handling and use of radioactive substances are performed;

(c)

every approved permanent premises complies with the requirements of, and is approved for use in accordance with, any written law relating to the preparation, storage, possession, use and disposal of radioactive substances.”.

New regulation 12A

11. In the principal Regulations, after regulation 12, insert —

“Additional requirements where applicable service provided using approved conveyances or at temporary premises

12A.—(1) This regulation applies to a licensee that is approved to provide an applicable service using an approved conveyance or at temporary premises.

(2) The licensee must establish a post‑relocation commissioning process to ensure the following:

(a)	that each piece of equipment used in every approved conveyance or temporary premises is adequate, functional and effective by recalibrating the equipment;
(b)	that any reagent used for the provision of the applicable service remains safe, suitable and effective for use.

(3) A licensee must implement the post‑relocation commissioning process mentioned in paragraph (2) each time before a licensee first provides the applicable service —

(a)	after the approved conveyance is moved to a new location; or
(b)	at any temporary premises.

(4) The licensee must establish and implement protocols for the management of any hazardous materials or waste, that are specific to each approved conveyance or temporary premises.”.

Amendment of regulation 14

12. In the principal Regulations, in regulation 14 —

(a)

in paragraph (1), replace “licensed premises or licensed conveyance” with “approved permanent premises, approved conveyance or temporary premises where an applicable service is provided”;

(b)

in paragraph (2), replace sub‑paragraph (b) with —

“(b)

where any radioactive substance or irradiating apparatus is used in the provision of the service —

(i)	radiation safety to ensure the safety of personnel and patients and other individuals within or in the vicinity of any premises used by the licensee for the provision of the service, including the proper handling, use and disposal of radioactive substances; and
(ii)	compliance with any written law governing the preparation, storage, possession, use and disposal of radioactive substances and irradiating apparatus;”;

(c)

in paragraph (2)(j), replace “the licensed premises or licensed conveyance” with “any approved permanent premises, approved conveyance or temporary premises where an applicable service is provided”; and

(d)

after paragraph (2), insert —

“(2A) The safety programme mentioned in paragraph (1) must also include the following:

(a)

where the licensee is a clinical laboratory service licensee who provides any testing service on radioactive specimens —

(i)

policies to protect any personnel who is pregnant against radiation exposure in the course of work and at every approved permanent premises, approved conveyance and temporary premises where the applicable service is provided; and

(ii)

measures to ensure that an adequate number of the following are available for use by all personnel:

(A)	suitable radiation monitoring devices, including dose calibrators and radiation survey meters;
(B)	suitable radiation shields and primary and second containers for transportation of radioactive substances within and outside the approved permanent premises;

(b)

where the licensee is a radiological service licensee —

(i)	policies to protect any personnel who is pregnant against radiation exposure in the course of work and at every approved permanent premises, approved conveyance and temporary premises where the applicable service is provided; and
(ii)	policies on the performance of ionising radiological procedures on pregnant women or women suspected to be pregnant.”.

Amendment of regulation 16

13. In the principal Regulations, in regulation 16, replace “the licensed premises or licensed conveyance” with “any approved permanent premises, approved conveyance or temporary premises where an applicable service is provided”.

Amendment of regulation 22

14. In the principal Regulations, in regulation 22(b), replace “date of expiry or beyond its shelf life” with “expiry date”.

New regulation 23A

15. In the principal Regulations, after regulation 23, insert —

“Tests on radioactive specimens

23A. A clinical laboratory licensee must not carry out any test or examination in relation to a radioactive specimen in any conveyance or at any premises other than the licensee’s approved permanent premises.”.

Amendment of regulation 26

16. In the principal Regulations, in regulation 26 —

(a)	replace “licensed premises and licensed conveyance” with “approved permanent premises, approved conveyance and temporary premises (other than residential premises) where a radiological service is provided”; and
(b)	in paragraph (a), replace “licensed premises or in the vicinity of the licensed conveyance” with “approved permanent premises or in the vicinity of the approved conveyance or temporary premises”.

Amendment of regulation 27

17. In the principal Regulations, in regulation 27(2), replace “minimally invasive image‑guided biopsy of breast, thyroid, any superficial lump or bump or any superficial lymph node” with “procedure mentioned in paragraph (e) of the definition of “radiological service” in paragraph 2 of the First Schedule to the Act”.

Amendment of regulation 30

18. In the principal Regulations, in regulation 30 —

(a)

after paragraph (a), insert —

“(aa)

the contrast agent is administered to the patient only at any of the licensee’s approved permanent premises;”; and

(b)

in paragraph (b), replace “licensed premises or licensed conveyance” wherever it appears with “approved permanent premises”.

Amendment of regulation 31

19. In the principal Regulations, in regulation 31 —

(a)

renumber the regulation as paragraph (1) of that regulation;

(b)

in paragraph (1)(e), replace “the licensed premises or licensed conveyance” with “any approved permanent premises, approved conveyance or temporary premises where the radiological service is provided”;

(c)

in paragraph (1)(e)(i) and (ii), replace “licensed premises or licensed conveyance” with “approved permanent premises, approved conveyance or temporary premises”; and

(d)

after paragraph (1), insert —

“(2) A radiological service licensee must ensure that the administration of any specified anaesthetic to a patient is performed in the provision of a radiological service only by an anaesthesiologist.

(3) A radiological service licensee must ensure that before a specified anaesthetic is administered to a patient, an anaesthesiologist assesses that the patient is a suitable candidate for the administration of specified anaesthetics.

(4) In this regulation —

“deep sedation” means a drug‑induced depression of a patient’s consciousness —

(a)	during which the patient cannot be easily aroused but will respond purposefully following repeated or painful stimulation;
(b)	where the patient’s ability to independently maintain ventilatory function may be impaired;
(c)	where the patient may require assistance in maintaining a patent airway and spontaneous ventilation may be inadequate; and
(d)	where the patient’s cardiovascular function is usually maintained;

“general anaesthesia” has the meaning given by paragraph 2 of the First Schedule to the Act;

“neuraxial anaesthesia” means the anaesthesia that is caused in a patient by the administration of an anaesthetic around the nerves of the central nervous system of the patient;

“specified anaesthetic” means an anaesthetic used to cause deep sedation, general anaesthesia or neuraxial anaesthesia.”.

Replacement of regulation 32 and new regulations 32A and 32B

20. In the principal Regulations, replace regulation 32 with —

“Testing of specimen

32. A radiological service licensee must not test any specimen for a patient unless —

(a)	a medical practitioner or dentist who is the licensee’s personnel orders the test for the patient;
(b)	the testing of the specimen only involves the conduct of a simple in vitro diagnostic test; and
(c)	the testing of the specimen is provided only as a service incidental to the provision of the radiological service.

Conduct of simple in vitro diagnostic test

32A.—(1) A radiological service licensee must ensure that any simple in vitro diagnostic test on a specimen or patient must be conducted —

(a)

using testing material in respect of which —

(i)	the expiry date has not passed; and
(ii)	the personnel who is administering the test does not suspect or have any reason to suspect that the testing material is no longer fit for use; and

(b)

in accordance with the instructions specified by the manufacturer of the testing material.

(2) A radiological service licensee must ensure that any testing material that is used to conduct any simple in vitro diagnostic testing is stored under the conditions, and handled in the manner, specified by the manufacturer of the testing material so as to lower the risk of contamination, unnecessary exposure of the testing material to the environment and early deterioration of the testing material.

Instructions for self‑collection of specimens

32B. Where any specimen is to be collected from a patient by the patient himself or herself, for the purpose of conducting any test on it (whether or not the test is to be self‑administered by the patient), a radiological service licensee must provide the patient with —

(a)	instructions on how and when the specimen is to be collected; and
(b)	the precautions that are to be taken to avoid contamination and degradation of the specimen.”.

Amendment of regulation 33

21. In the principal Regulations, in regulation 33 —

(a)

renumber the regulation as paragraph (1) of that regulation;

(b)

in paragraph (1), replace sub‑paragraph (b) with —

“(b)

in relation to any radiological examination —

(i)

a medical practitioner registered under section 22 of the Medical Registration Act 1997 as a specialist in the branch of diagnostic radiology; or

(ii)

a medical practitioner who is —

(A)	a diagnostic radiology resident; and
(B)	a member of the Fellowship of the Royal College of Radiologists or any equivalent professional association of radiologists; and”;

(c)

in paragraph (1)(c)(ii), delete “and” at the end;

(d)

in paragraph (1)(c)(iii), replace “x‑ray” with “radiography”;

(e)

in paragraph (1)(c)(iii)(C), replace “Radiologists.” with “Radiologists or any equivalent professional association of radiologists; and”;

(f)

in paragraph (1)(c), after sub‑paragraph (iii), insert —

“(iv)

in relation to a plain radiography image — a medical practitioner who —

(A)	is a diagnostic radiology resident; and
(B)	has passed the National Plain Film Test administered by the College of Radiologists, Singapore.”; and

(g)

after paragraph (1), insert —

“(2) In this regulation, “diagnostic radiology resident” means a medical practitioner who is receiving training under a diagnostic radiology residency programme that is accredited by the Joint Committee on Specialist Training appointed by the Specialists Accreditation Board established under section 34(1) of the Medical Registration Act 1997.”.

Amendment of regulation 35

22. In the principal Regulations, in regulation 35 —

(a)

in paragraph (1), replace sub‑paragraph (a) with —

“(a)

the following information about the licensee issuing the report:

(i)	the licensee’s name and the business name (if different from the licensee’s name) by which the licensee provides the applicable service;
(ii)	the licensee’s address;”;

(b)

in paragraph (1), replace sub‑paragraph (c) with —

“(c)	subject to paragraph (1A), the address of the premises at which or the vehicle number of the approved conveyance in which the test or radiological examination is conducted;”;

(c)

in paragraph (1)(g), delete sub‑paragraph (ii);

(d)

in paragraph (1)(h), delete “and time”; and

(e)

after paragraph (1), insert —

“(1A) Where the premises at which the test or radiological examination is conducted are temporary premises that are residential premises, the licensee issuing the report may, instead of stating the address of those premises in the clinical laboratory report or radiological report (as the case may be), indicate that the test or radiological examination was conducted at residential premises.”.

Amendment of regulation 36

23. In the principal Regulations, in regulation 36 —

(a)	in the regulation heading, replace “reports” with “results or findings”; and
(b)	replace “clinical laboratory report or radiological report” with “test or radiological examination”.

Amendment of regulation 37

24. In the principal Regulations, in regulation 37 —

(a)

renumber the regulation as paragraph (1) of that regulation;

(b)

in paragraph (1), replace “A” with “Subject to paragraph (2), a”; and

(c)

after paragraph (1), insert —

“(2) Paragraph (1) does not apply in relation to an incidental finding in any genetic test if the patient in respect of whom the clinical laboratory report is issued or the requestor informs the licensee that the patient does not wish to be informed of any incidental finding.”.

Amendment of regulation 43

25. In the principal Regulations, in regulation 43, after paragraph (a), insert —

“(aa)

where the test was conducted at temporary premises that are residential premises — the address of those residential premises;”.

Replacement of regulation 44

26. In the principal Regulations, replace regulation 44 with —

“Radiological service licensee — records to be kept in relation to each radiological examination

44.—(1) A radiological service licensee must keep records of all of the following in relation to each radiological examination that the licensee conducts:

(a)

the date, time and type of radiological examination;

(b)

where the radiological examination was conducted at temporary premises that are residential premises — the address of those residential premises;

(c)

the name of the person who conducted the radiological examination;

(d)

the name of the person who reported and issued the radiological report;

(e)

each radiological image obtained from the radiological examination;

(f)

in relation to the examination —

(i)

information about the site of the anatomic site imaged; and

(ii)

where any images are provided by the licensee directly to another person together with the radiological report —

(A)	the person to whom the images were provided; and
(B)	the mode by which the images were provided to that person;

(g)

in relation to any contrast agent administered to a patient during the examination —

(i)	the name and dose of the contrast agent;
(ii)	the route and rate of administration of the contrast agent; and
(iii)	any adverse reaction experienced by the patient following or associated with the administration of the contrast agent;

(h)

where the radiological examination involves the administration of any anaesthetic or sedative to the patient —

(i)

information relating to the anaesthetic or sedative administered; and

(ii)

information relating to the safety of patients and personnel, including information relating to —

(A)	any adverse reaction experienced by any patient following or associated with the administration of any anaesthetic or sedative, including any investigation into the cause of the adverse reaction; and
(B)	any incident occurring in the course of or in relation to the examination of any patient that affected or potentially affected the safety of the patient or any personnel, including any investigation and follow‑up action taken.

(2) The radiological service licensee must keep an accurate and complete copy of the radiological report of each radiological examination that the licensee conducts.”.

New regulation 44A

27. In the principal Regulations, after regulation 44, insert —

“Tracing of records from report

44A. A licensee must, in relation to any report mentioned in regulation 34(1) or (2) for a test or radiological examination, implement a system that enables the licensee to retrieve all records mentioned in regulation 42, 43 or 44 relating to the test or radiological examination.”.

Amendment of regulation 48

28. In the principal Regulations, in regulation 48(1) —

(a)	replace “12(1) or (2),” with “12(1), (2) or (3), 12A(2), (3) or (4),”;
(b)	replace “24,” with “23A,”;
(c)	replace “31,” with “31(1), (2) and (3),”; and
(d)	replace “34(1) or (2),” with “34(2),”.

Miscellaneous amendments

29. In the principal Regulations, in the following provisions, replace “Director” with “Director‑General”:

Regulation 2, definition of “requestor”, paragraph (b)

Regulation 5(b)(iii) and (iv)

Regulation 41(1)(b) and (c).

New Schedule

30. In the principal Regulations, after regulation 48, insert —

“THE SCHEDULE

Regulations 2, 4 and 4B

Part 1

Specified services for clinical laboratory service

The following are specified services for a clinical laboratory service:

(a)

a testing service in any of the following laboratory disciplines:

(i)	anatomic pathology;
(ii)	chemical pathology, excluding the provision of the test set out in sub‑paragraph (b)(vi);
(iii)	clinical toxicology;
(iv)	cytology;
(v)	cytogenetics;
(vi)	haematology, excluding the provision of the test set out in sub‑paragraph (b)(vii);
(vii)	histocompatibility;
(viii)	immunology, excluding the provision of the tests set out in sub‑paragraph (b)(i) and (ii);
(ix)	medical microbiology, excluding the provision of the tests set out in sub‑paragraph (b)(v) and (viii);
(x)	transfusion medicine;
(xi)	molecular pathology, excluding the provision of the tests set out in sub‑paragraph (b)(iii) and (iv);

(b)

the provision of any of the following tests:

(i)	human immunodeficiency virus screening;
(ii)	human immunodeficiency virus confirmation;
(iii)	pre‑implantation genetic testing for monogenic or single gene defects;
(iv)	pre‑implantation genetic testing for chromosomal structural rearrangements;
(v)	acid‑fast bacilli smear testing;
(vi)	glycated haemoglobin (haemoglobin A1c) testing;
(vii)	malaria parasite testing;
(viii)	molecular SARS‑CoV‑2 testing for Coronavirus Disease 2019 (COVID‑19).

Part 2

Specified services for radiological service

The following are specified services for a radiological service:

(a)

the provision of an imaging service by any of the following imaging modalities, excluding the provision of any procedure mentioned in paragraph (b):

(i)	plain radiography;
(ii)	mammography;
(iii)	fluoroscopy;
(iv)	computed tomography;
(v)	cone beam computed tomography;
(vi)	magnetic resonance imaging;

(b)

the provision of minimally invasive image‑guided biopsy of breast, thyroid, superficial lump or bump, or any superficial lymph node.”.

Made on 21 June 2023.

CHAN YENG KIT

Permanent Secretary,
Ministry of Health,
Singapore.

[MH 78:44/1; AG/LEGIS/SL/122E/2020/19 Vol. 1]

Search within Legislation